研报掘金丨中信建投:维持鱼跃医疗“买入”评级,下半年海外收入有望增速提升
Ge Long Hui A P P·2025-10-13 08:13

Core Viewpoint - Yuyue Medical's Q2 revenue and net profit attributable to shareholders met expectations, with net profit slightly exceeding expectations due to increased government subsidies in non-recurring gains during the first half of the year [1] Group 1: Financial Performance - Q2 revenue and net profit attributable to shareholders were in line with expectations, while net profit slightly exceeded expectations [1] - Significant growth observed in home respiratory devices, continuous glucose monitoring (CGM), and emergency business sectors [1] - Steady growth in home health testing business [1] Group 2: Future Outlook - Domestic business is expected to maintain steady growth due to the recovery of consumer demand and continuous market share increase [1] - Overseas business is anticipated to see accelerated growth [1] - The company is advancing its internationalization, smart technology, and wearable strategy [1] Group 3: Product Development and Strategy - Continuous iteration and diversification of new products are underway [1] - AI empowerment is expected to help create a platform ecosystem for home medical devices [1] - The company aims to further solidify its position as a leading platform-type enterprise in home medical devices [1]